Stryker logo

SYK - Stryker Share Price

$257.13 0.3  0.1%

Last Trade - 16/04/21

Large Cap
Market Cap £69.97bn
Enterprise Value £77.90bn
Revenue £10.38bn
Position in Universe 133rd / 6850
Unlock SYK Revenue
Relative Strength (%)
1m +2.21%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -1.10%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
9,946 11,325 12,444 13,601 14,884 14,351 17,091 18,331 +7.6%
+89.4 +13.4 +13.8 +80.3 -35.8 -11.0 +47.1 +13.0
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, StrykerCorporation revenues decreased 4% to $14.35B. Net incomedecreased 23% to $1.6B. Revenues reflect Orthopaedicssegment decrease of 6% to $4.96B, MedSurg Equipment segmentdecrease of 3% to $6.4B, Neurotechnology and Spine segmentdecrease of 2% to $2.99B, United States segment decrease of5% to $10.46B, Europe & Middle East & Africa (EMEA)(Region) segment decrease of 4% to $1.82B.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for SYK
Graphical History


SYK Revenue Unlock SYK Revenue

Net Income

SYK Net Income Unlock SYK Revenue

Normalised EPS

SYK Normalised EPS Unlock SYK Revenue

PE Ratio Range

SYK PE Ratio Range Unlock SYK Revenue

Dividend Yield Range

SYK Dividend Yield Range Unlock SYK Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
SYK EPS Forecasts Unlock SYK Revenue
Profile Summary

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. Its segments include Orthopaedics, MedSurg, Neurotechnology and Spine. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products. The MedSurg segment includes surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment, intensive care disposable products; reprocessed and remanufactured medical devices, and other related products. The Neurotechnology and Spine segment includes neurovascular products, spinal implant systems and other related products. Its products include implants, which are used in joint replacement and trauma surgeries, and other products. It offers musculoskeletal care and sensor technology for total joint replacement.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated February 20, 1946
Public Since July 24, 1997
No. of Shareholders: 2,582
No. of Employees: 43,000
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 376,324,529
Free Float (0.0%)
Eligible for
SYK Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for SYK
Upcoming Events for SYK
Tuesday 27th April, 2021
Q1 2021 Stryker Corp Earnings Release
Tuesday 27th April, 2021
Q1 2021 Stryker Corp Earnings Call
Wednesday 5th May, 2021
Stryker Corp Annual Shareholders Meeting
Wednesday 5th May, 2021 Estimate
Stryker Corp Annual Shareholders Meeting
Wednesday 28th July, 2021 Estimate
Q2 2021 Stryker Corp Earnings Release
Frequently Asked Questions for Stryker
What is the Stryker share price?

As of 16/04/21, shares in Stryker are trading at $257.13, giving the company a market capitalisation of £69.97bn. This share price information is delayed by 15 minutes.

How has the Stryker share price performed this year?

Shares in Stryker are currently trading at $257.13 and the price has moved by 47.09% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Stryker price has moved by 1.39% over the past year.

What are the analyst and broker recommendations for Stryker?

Of the analysts with advisory recommendations for Stryker, there are there are currently 9 "buy" , 12 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Stryker is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Stryker next release its financial results?

Stryker is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Stryker dividend yield?

The Stryker dividend yield is 1.14% based on the trailing twelve month period.

Does Stryker pay a dividend?

Last year, Stryker paid a total dividend of 2.93, and it currently has a trailing dividend yield of 1.14%. Looking ahead, Stryker has not announced an ex-dividend date yet and the next dividend pay date is 2021-04-30.

When does Stryker next pay dividends?

Stryker has yet to annouce their ex-dividend date and the next dividend pay date is 2021-04-30. The historic dividend yield on Stryker shares is currently 1.14%.

How do I buy Stryker shares?

To buy shares in Stryker you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Stryker?

Shares in Stryker are currently trading at $257.13, giving the company a market capitalisation of £69.97bn.

Where are Stryker shares listed? Where are Stryker shares listed?

Here are the trading details for Stryker:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: SYK
What kind of share is Stryker?

Based on an overall assessment of its quality, value and momentum, Stryker is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Stryker share price forecast 2021?

Shares in Stryker are currently priced at $257.13. At that level they are trading at 1.56% premium to the analyst consensus target price of 0.00.

Analysts covering Stryker currently have a consensus Earnings Per Share (EPS) forecast of 9.073 for the next financial year.

How can I tell whether the Stryker share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Stryker. Over the past six months, the relative strength of its shares against the market has been -5.7%. At the current price of $257.13, shares in Stryker are trading at 16.02% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Stryker PE Ratio?

The Stryker PE ratio based on its reported earnings over the past 12 months is 41.7. The shares are currently trading at $257.13.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Stryker?

Stryker's management team is headed by:

Timothy Scannell - PRE
Srikant Datar - IND
Roch Doliveux - IND
Allan Golston - LED
Kevin Lobo - CHM
William Berry - CAO
Glenn Boehnlein - CFO
Yin Becker - VPR
M. Kathryn Fink - CHO
Mary Brainerd - IND
Viju Menon - CEX
Robert Fletcher - VPR
Preston Wells - VPR
Giovanni Caforio - IND
Who are the major shareholders of Stryker?

Here are the top five shareholders of Stryker based on the size of their shareholding:

T. Rowe Price Associates, Inc. Investment Advisor
Percentage owned: 7.94% (29.9m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 7.57% (28.5m shares)
Greenleaf Trust Bank and Trust
Percentage owned: 5.53% (20.8m shares)
Brown (John W) Individual Investor
Percentage owned: 5.33% (20.1m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 4.41% (16.6m shares)
Similar to SYK
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.